|
ABOUT COMPANY
Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotech company, develops a platform for single-acting or bispecific biologics. The company is headquartered in Princeton, New Jersey.
|
EARNINGS
Gross Profit (TTM): -15728114
Market Capitalization: 24889500
Operating Margin (TTM): -51.87
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.02
Revenue (TTM): 483630
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.018
Dividend Date: 2020-04-02
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: None
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|